Showing 67,581 - 67,600 results of 104,490 for search '(( 5 ((mean decrease) OR (a decrease)) ) OR ( e ((fold decrease) OR (point decrease)) ))', query time: 1.10s Refine Results
  1. 67581
  2. 67582

    Negative frequency-dependence maintaining coexistence between BCs and ICs. by Albertas Janulevicius (732672)

    Published 2021
    “…(C) Rate of UG, <i>v</i><sub>up</sub> (lines, left axis), as a function of intracellular ATP concentration (<a href="http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.1008547#pcbi.1008547.e001" target="_blank">Eq 1</a>) for BCs and ICs at [Glc] = 2mM. …”
  3. 67583

    Image_1_Immunomodulatory potential of mesenchymal stromal cell-derived extracellular vesicles in chondrocyte inflammation.jpg by Robert Ossendorff (16653054)

    Published 2023
    “…These findings were supported by a decrease in matrix differentiation (COL-II). …”
  4. 67584

    DataSheet_1_Immunomodulatory potential of mesenchymal stromal cell-derived extracellular vesicles in chondrocyte inflammation.docx by Robert Ossendorff (16653054)

    Published 2023
    “…These findings were supported by a decrease in matrix differentiation (COL-II). …”
  5. 67585

    Viral replicative advantages and pathological consequences related to STAT3-altered function. by Armando Andres Roca Suarez (4967134)

    Published 2018
    “…ANGPTL4, angiopoietin-like protein 4; APR, acute phase response; BIRC5, baculoviral IAP repeat-containing protein 5; CCL5, C-C motif chemokine ligand 5; DCs, dendritic cells; DC-SIGN, dendritic cell-specific ICAM-3-grabbing non-integrin 1; EBV, Epstein–Barr virus; FOS, proto-oncogene c-Fos; HCC, hepatocellular carcinoma; HCMV, human cytomegalovirus; HCV, hepatitis C virus; HEV, hepatitis E virus; HSCs, hepatic stellate cells; IAV, influenza A virus; IDO1, indoleamine 2,3-dioxygenase 1; IL-10, interleukin 10; ISG, interferon-stimulated gene; JUN, proto-oncogene c-Jun; KSHV, Kaposi’s sarcoma-associated herpesvirus; MCL1, induced myeloid leukemia cell differentiation protein Mcl-1; MDSCs, myeloid-derived suppressor cells; MT, microtubule; MUC1, mucin 1 cell surface associated; MuV, mumps virus; NPC, nasopharyngeal carcinoma; NR4A2, nuclear receptor subfamily 4 group A member 2; PCBP2, poly(rC)-binding protein 2; PD-L1, programmed cell death 1 ligand 1; RTA, R transactivator; RVFV, Rift Valley fever virus; STAT3, signal transducer and activator of transcription 3; TGF-β, transforming growth factor beta; T<sub>reg</sub>, regulatory CD4<sup>+</sup> T cell; VZV, varicella-zoster virus.…”
  6. 67586

    Image_3_Immunomodulatory potential of mesenchymal stromal cell-derived extracellular vesicles in chondrocyte inflammation.jpg by Robert Ossendorff (16653054)

    Published 2023
    “…These findings were supported by a decrease in matrix differentiation (COL-II). …”
  7. 67587

    Image_4_Immunomodulatory potential of mesenchymal stromal cell-derived extracellular vesicles in chondrocyte inflammation.jpg by Robert Ossendorff (16653054)

    Published 2023
    “…These findings were supported by a decrease in matrix differentiation (COL-II). …”
  8. 67588

    Image_2_Immunomodulatory potential of mesenchymal stromal cell-derived extracellular vesicles in chondrocyte inflammation.jpg by Robert Ossendorff (16653054)

    Published 2023
    “…These findings were supported by a decrease in matrix differentiation (COL-II). …”
  9. 67589

    Week 6 & 7 Experimental Design: Impact of the Anthropocene on bug abundance by Naduni Kurukulasooriya (795949)

    Published 2015
    “…Every 5 meters was considered a new group, the first 5 meters was Group 1 and the last was Group 6. …”
  10. 67590

    Taxonomic and Functional Metagenomic Signature of Turfs in the Abrolhos Reef System (Brazil) by Juline M. Walter (3070701)

    Published 2016
    “…Their presence is associated with a reduction in three-dimensional coral reef complexity and decreases the habitats available for reef biodiversity. …”
  11. 67591

    Curcumin suppresses cell proliferation and clonogenic ability of AtT20 cells. by Madhavi Latha Yadav Bangaru (365520)

    Published 2013
    “…<p>(<i>A</i>) AtT20 cells were treated with the indicated concentrations of curcumin and cell proliferation was determined by MTT assay after 4 days. …”
  12. 67592

    Expression of whole peripheral blood biomarkers exposed to chronic hypoxia. by Matias Mosqueira (162817)

    Published 2012
    “…<p>Real time qPCR was normalized using the expression of β-actin as a housekeeping control. A. CD36 as a marker for erythropoiesis increased the expression level during chronic hypoxia (CH), but decreased below normoxic levels during REC. …”
  13. 67593

    Med promotes bone regeneration at the drill hole site in Ovx osteopenic rats. by Manisha Dixit (777718)

    Published 2015
    “…<sup>c</sup><i>P</i>< 0.001 compjared with Sham + vehicle group; <sup>b</sup><i>P</i>< 0.01compared with Sham + vehicle group; <sup>a</sup><i>P</i>< 0.05compared with Sham + vehicle group; <sup>z</sup><i>P</i>< 0.001 compared with Ovx + vehicle group; <sup>y</sup><i>P</i>< 0.01 compared with Ovx + vehicle group; <sup>x</sup><i>P</i>< 0.05 compared with Ovx + vehicle group; <sup>r</sup><i>P</i>< 0.001 compared with Ovx + 0.5mg/kg med group; <sup>p</sup><i>P</i>< 0.05 compared with Ovx + 0.5mg/kg med group; <sup>l</sup><i>P</i>< 0.001 compared with Ovx + 1.0mg/kg med group; <sup>k</sup><i>P</i>< 0.01 compared with Ovx + 1.0mg/kg med group; <sup>j</sup><i>P</i>< 0.05 compared with Ovx + 1.0mg/kg med group; <sup>o</sup><i>P</i>< 0.001 compared with Ovx + 5.0mg/kg med group; <sup>m</sup><i>P</i>< 0.05 compared with Ovx + 5.0mg/kg med group.…”
  14. 67594

    Pax6 represses SPBP-mediated enhancement of AR activity. by Julianne Elvenes (205103)

    Published 2011
    “…HEK293 cells were cultured in medium with charcoal treated serum and cotransfected with 75 ng pDestHA-AR, 50 or 150 ng pDestHA-SPBP, 0–25 ng pDestHA-Pax6, 75 ng p285PB-Luc, and 5 ng pCMV-βgal. The experiment was performed and data obtained as described in A. …”
  15. 67595

    Table_2_Sleep Disorders in Leucine-Rich Glioma-Inactivated Protein 1 and Contactin Protein-Like 2 Antibody-Associated Diseases.DOCX by Nan Lin (26755)

    Published 2020
    “…Twenty-one PSG recordings from patients with LGI1-Ab encephalitis demonstrated a decrease in total sleep time (TST) (median 365.5, range 184.5–495.5 min), sleep efficiency (70.0%, 47–92%), N3 sleep (9.7%, 0–32.9%), and REM sleep (9.9%, 0.4–27.9%). …”
  16. 67596

    Table_1_Sleep Disorders in Leucine-Rich Glioma-Inactivated Protein 1 and Contactin Protein-Like 2 Antibody-Associated Diseases.DOCX by Nan Lin (26755)

    Published 2020
    “…Twenty-one PSG recordings from patients with LGI1-Ab encephalitis demonstrated a decrease in total sleep time (TST) (median 365.5, range 184.5–495.5 min), sleep efficiency (70.0%, 47–92%), N3 sleep (9.7%, 0–32.9%), and REM sleep (9.9%, 0.4–27.9%). …”
  17. 67597

    Table_2_Sleep Disorders in Leucine-Rich Glioma-Inactivated Protein 1 and Contactin Protein-Like 2 Antibody-Associated Diseases.DOCX by Nan Lin (26755)

    Published 2020
    “…Twenty-one PSG recordings from patients with LGI1-Ab encephalitis demonstrated a decrease in total sleep time (TST) (median 365.5, range 184.5–495.5 min), sleep efficiency (70.0%, 47–92%), N3 sleep (9.7%, 0–32.9%), and REM sleep (9.9%, 0.4–27.9%). …”
  18. 67598

    Table_1_Sleep Disorders in Leucine-Rich Glioma-Inactivated Protein 1 and Contactin Protein-Like 2 Antibody-Associated Diseases.DOCX by Nan Lin (26755)

    Published 2020
    “…Twenty-one PSG recordings from patients with LGI1-Ab encephalitis demonstrated a decrease in total sleep time (TST) (median 365.5, range 184.5–495.5 min), sleep efficiency (70.0%, 47–92%), N3 sleep (9.7%, 0–32.9%), and REM sleep (9.9%, 0.4–27.9%). …”
  19. 67599

    Temporal Trend in Young-Onset Type 2 Diabetes - the Macrovascular and Mortality Risk: Study of UK Primary Care Electronic Medical Records by Digsu N. Koye (8881108)

    Published 2020
    “…The incidence rates of ASCVD and ACM declined in people aged ≥50 years, but did not decrease in people <50 years. Compared to people aged ≥50 years, those aged 18-39 years at diagnosis had higher obesity (71% obese), higher HbA1c (8.6%), 71% had high LDL-C, while only 18% were on cardio-protective therapy. …”
  20. 67600